Barclays reports US tobacco data shows cigarette volume decline By Investing.com

US tobacco volumes remain under pressure, with cigarette volumes down 4.3% to 5.5% year over year and year-to-date volumes off 5.1%, though still better than Barclays’ 7.3% decline estimate. Nicotine pouch sales are the relative bright spot, with 22% value and volume growth year over year, led by ZYN at about $260 million in four-week retail sales. In combustibles, Altria, BAT, and Imperial all posted cigarette volume declines, while e-cigarette sales fell 17% overall and disposable vapor sales dropped 34.7% year over year.

Analysis

The clearest relative winner is the modern oral nicotine bucket, but the market is still mispricing the speed of share transfer inside that category. ZONE’s early traction is small, yet the key implication is that nicotine pouches are becoming a brand-driven rather than format-driven market: if shelf productivity keeps improving, retailers will rationalize facings toward the fastest-turning SKUs, which tends to compound for the leaders and starve the laggards. That dynamic is more dangerous for smaller pouch brands than for ZYN, but it also raises the bar for everyone else because price competition can re-accelerate once the channel is forced to allocate by velocity.

For MO and BTI, the more important signal is not the headline volume pressure, but the mix of where the decline is occurring. Combustibles are deteriorating while alternative nicotine is not yet fully offsetting the decline, which means earnings quality should remain under pressure even if top-line unit declines look manageable. The second-order effect is on trade spend and promotional intensity: as cigarette shelf space becomes less productive, wholesalers and retailers will demand more support, compressing margins before the volume hit fully shows up in consensus models.

The e-cigarette read-through is bearish for the broad category but potentially bullish for the best-positioned closed-system players over a 6-12 month horizon. Weak disposables can actually improve the industry structure by forcing consumers toward refill and pod ecosystems where switching costs are higher, but that only helps if product cadence and regulatory compliance remain intact. The market is likely underestimating how much of the apparent decline is a channel-cleansing event versus permanent demand loss; if enforcement tightens further, current reported volumes could trough before consumer demand does.

Key Decisions for Investors

• Long ZONE vs short MO over the next 3-6 months: ZONE has asymmetric upside if pouch share continues to consolidate, while MO faces margin pressure from declining combustibles and rising support costs. Use a 1.5-2.0x stop on the pair if ZONE share gains stall for two consecutive monthly prints.
• Buy MO out-of-the-money put spreads expiring in 6-9 months: the market is likely too complacent on the combination of combustibles erosion and trade-spend compression. Structure for a modest debit and target a 2-3x payoff if share gains fail to offset category decline.
• Short BTI on any 2-3% relief rally, with a 3-6 month horizon: the name looks like the weakest execution story among the large-cap tobacco complex, and relative underperformance should persist unless alternative nicotine traction materially improves. Cover if the next two monthly volume reports show sequential stabilization.
• Pair long Velo/Imperial exposure via IMB over long MO: the better pouch momentum argues for owning the newer nicotine mix versus legacy combustibles. This is a tactical relative-value trade, not a secular long, with a 10-15% upside target versus a 7-10% downside stop.
• For e-cig exposure, prefer selective closed-system optionality over broad category longs: if the selloff in disposables continues, consider a small tactical long in the strongest closed-tank winner only after one more month of confirming volume stability. The risk/reward is better after the channel washout than before it.